MX2010009488A - Métodos para modular la actividad del receptor de mc5, y tratamiento de las afecciones relacionadas con este receptor. - Google Patents
Métodos para modular la actividad del receptor de mc5, y tratamiento de las afecciones relacionadas con este receptor.Info
- Publication number
- MX2010009488A MX2010009488A MX2010009488A MX2010009488A MX2010009488A MX 2010009488 A MX2010009488 A MX 2010009488A MX 2010009488 A MX2010009488 A MX 2010009488A MX 2010009488 A MX2010009488 A MX 2010009488A MX 2010009488 A MX2010009488 A MX 2010009488A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor
- modulating
- activity
- treatment
- methods
- Prior art date
Links
- 102000030612 Melanocortin 5 receptor Human genes 0.000 abstract 3
- 108010088565 Melanocortin 5 receptor Proteins 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000008742 seborrheic dermatitis Diseases 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010039792 Seborrhoea Diseases 0.000 abstract 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000003828 downregulation Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3291208P | 2008-02-29 | 2008-02-29 | |
| US12/391,748 US8377925B2 (en) | 2008-02-29 | 2009-02-24 | Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor |
| PCT/AU2009/000231 WO2009105824A1 (en) | 2008-02-29 | 2009-02-27 | Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010009488A true MX2010009488A (es) | 2011-03-02 |
Family
ID=41015441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010009488A MX2010009488A (es) | 2008-02-29 | 2009-02-27 | Métodos para modular la actividad del receptor de mc5, y tratamiento de las afecciones relacionadas con este receptor. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2257297B1 (enExample) |
| JP (1) | JP5503558B2 (enExample) |
| KR (1) | KR101620115B1 (enExample) |
| CN (1) | CN102006873B (enExample) |
| AU (1) | AU2009219107B2 (enExample) |
| BR (1) | BRPI0907906A2 (enExample) |
| CA (1) | CA2716316C (enExample) |
| IL (1) | IL207833B (enExample) |
| MX (1) | MX2010009488A (enExample) |
| NZ (1) | NZ587361A (enExample) |
| RU (1) | RU2555343C9 (enExample) |
| WO (1) | WO2009105824A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8008291B2 (en) * | 2008-02-29 | 2011-08-30 | Mimetica Pty Ltd | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| EP2257533B1 (en) * | 2008-02-29 | 2013-09-18 | Mimetica Pty Limited | 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| EP3288534B1 (en) | 2015-04-28 | 2020-09-23 | Symrise AG | Compositions comprising valerian extracts |
| GB201808149D0 (en) | 2018-05-18 | 2018-07-11 | Univ Court Univ Of Glasgow | Protected amino acids |
| CN115381955B (zh) * | 2021-05-24 | 2024-05-17 | 中国科学技术大学 | 黑皮质素受体mc5r的用途 |
| CN114478210A (zh) * | 2022-02-26 | 2022-05-13 | 江苏壹药新材料有限公司 | 一种7-氯萘-2-甲醛的合成方法 |
| CN115232015B (zh) * | 2022-07-06 | 2024-01-02 | 暨明医药科技（苏州）有限公司 | 一种氯喹手性侧链的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6A (en) * | 1836-08-10 | Thomas Blanchard | Machine for forming end pieces of plank blocks for ships | |
| AUPP254898A0 (en) * | 1998-03-24 | 1998-04-23 | University Of Queensland, The | Peptide turn mimetics |
| CN1816337A (zh) * | 2003-05-01 | 2006-08-09 | 帕拉坦技术公司 | 黑素皮质素受体特异性化合物 |
| WO2008017852A1 (en) | 2006-08-11 | 2008-02-14 | Palatin Technologies, Inc. | Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators |
| US8008291B2 (en) * | 2008-02-29 | 2011-08-30 | Mimetica Pty Ltd | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| EP2257533B1 (en) * | 2008-02-29 | 2013-09-18 | Mimetica Pty Limited | 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
-
2009
- 2009-02-27 JP JP2010547918A patent/JP5503558B2/ja not_active Expired - Fee Related
- 2009-02-27 EP EP09716086.5A patent/EP2257297B1/en not_active Not-in-force
- 2009-02-27 NZ NZ587361A patent/NZ587361A/en not_active IP Right Cessation
- 2009-02-27 WO PCT/AU2009/000231 patent/WO2009105824A1/en not_active Ceased
- 2009-02-27 CA CA2716316A patent/CA2716316C/en active Active
- 2009-02-27 KR KR1020107021384A patent/KR101620115B1/ko not_active Expired - Fee Related
- 2009-02-27 BR BRPI0907906-8A patent/BRPI0907906A2/pt not_active Application Discontinuation
- 2009-02-27 MX MX2010009488A patent/MX2010009488A/es active IP Right Grant
- 2009-02-27 AU AU2009219107A patent/AU2009219107B2/en not_active Ceased
- 2009-02-27 RU RU2010137030/15A patent/RU2555343C9/ru active
- 2009-02-27 CN CN2009801130048A patent/CN102006873B/zh not_active Expired - Fee Related
-
2010
- 2010-08-26 IL IL207833A patent/IL207833B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL207833A0 (en) | 2010-12-30 |
| EP2257297B1 (en) | 2017-10-18 |
| NZ587361A (en) | 2012-07-27 |
| CA2716316A1 (en) | 2009-09-03 |
| IL207833B (en) | 2018-02-28 |
| BRPI0907906A2 (pt) | 2020-08-18 |
| KR20100134614A (ko) | 2010-12-23 |
| JP2011513245A (ja) | 2011-04-28 |
| WO2009105824A1 (en) | 2009-09-03 |
| EP2257297A1 (en) | 2010-12-08 |
| CN102006873B (zh) | 2013-09-18 |
| CN102006873A (zh) | 2011-04-06 |
| CA2716316C (en) | 2017-05-30 |
| RU2555343C9 (ru) | 2015-11-27 |
| EP2257297A4 (en) | 2012-02-22 |
| RU2010137030A (ru) | 2012-04-10 |
| AU2009219107B2 (en) | 2013-11-21 |
| RU2555343C2 (ru) | 2015-07-10 |
| KR101620115B1 (ko) | 2016-05-12 |
| JP5503558B2 (ja) | 2014-05-28 |
| AU2009219107A1 (en) | 2009-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201200473A1 (ru) | Замещенные (гетероарилметил)тиогидантоины | |
| CA2871471C (en) | Dna-pk inhibitors | |
| MX2010004857A (es) | Compuestos de benzodiazepinona utiles en el tratamiento de afecciones de la piel. | |
| BR112013033182A2 (pt) | compostos imidazopiridinil-aminopiridina substituída | |
| MX2010009488A (es) | Métodos para modular la actividad del receptor de mc5, y tratamiento de las afecciones relacionadas con este receptor. | |
| EA201290041A1 (ru) | Лечение расстройств, связанных с макрофагами | |
| MY162933A (en) | Chemical compounds | |
| TN2012000555A1 (en) | Antibodies to human gdf8 | |
| MX2010004074A (es) | Combinacion 059. | |
| MX2011013816A (es) | Pirimidinonas como inhibidores de pi3k. | |
| TN2011000627A1 (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
| MX2011011735A (es) | Compuestos y metodos para la inhibicion de renina, e indicaciones para ello. | |
| EA019744B9 (ru) | Изотиазолилоксифениламидины и их применение для борьбы с фитопатогенными грибами и семенной материал, обработанный изотиазолилоксифениламидинами | |
| MX2012006822A (es) | 1,7-diazacarbazoles y metodos de uso. | |
| DE602006012013D1 (de) | Proteasom-hemmer und verwendungsverfahren dafür | |
| MX2011006006A (es) | Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos. | |
| MY186456A (en) | Quinazoline carboxamide azetidines | |
| MX2011009493A (es) | Compuestos para el tratamiento de trastornos metabolicos. | |
| MX348024B (es) | Compuestos de adamantilo. | |
| MY150600A (en) | Use of opioid antagonists for treating urinary retention | |
| WO2010097788A3 (en) | Visfatin therapeutic agents for the treatment of acne and other conditions | |
| PH12012501402A1 (en) | Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease | |
| EA201170672A1 (ru) | Соединения, пригодные для лечения целлюлита | |
| MX2013002121A (es) | Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |